Structure Info
- Chemspace ID
- CSCS00021427318 (Synthesis)
- MFCD
- MFCD31558548
- IUPAC Name
- 2-(2-chloro-8-fluoroquinazolin-4-yl)acetic acid
- Mol formula
- C10H6ClFN2O2
- Mol weight
- 241 Da
- Catalog Number(s)
- AC4788, AC4788-0.25G, BBV-95933136, BD01121791, CSC021427318, D777162, FCH7072605, JWC61317, LN04956791, SY100579
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.5
- Heavy atoms count
- 16
- Rotatable bond count
- 2
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.1
- Polar surface area (Å)
- 63
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSCS00021427318
Items Overall 9 items from 6 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, € | Qty |
|---|---|---|---|---|---|---|
| FCH Group | 28 days | Ukraine To: | 95 | 1 g | 1,101 | |
Description: 2-(2-chloro-8-fluoroquinazolin-4-yl)acetic acid; CAS: 1784613-17-7 | ||||||
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 250 mg | 587 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 1 g | 1,469 | |
Description: Name:2-(2-Chloro-8-fluoroquinazolin-4-yl)acetic acid; CAS: 1784613-17-7 | ||||||
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 250 mg | 587 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 1 g | 1,469 | |
Description: Name:2-(2-Chloro-8-fluoroquinazolin-4-yl)acetic acid; CAS: 1784613-17-7 | ||||||
| Accela ChemBio Inc. | 30 days | United States To: | 95 | 1 g | 695 | |
Description: 2-Chloro-8-fluoroquinazoline-4-acetic Acid; CAS: 1784613-17-7 | ||||||
| Accela ChemBio Inc. CN | 30 days | China To: | 95 | 1 g | 695 | |
Description: 2-Chloro-8-fluoroquinazoline-4-acetic Acid; CAS: 1784613-17-7 | ||||||
| Astatech CN | 40 days | China To: | 95 | 250 mg | 788 | |
| Astatech CN | 40 days | China To: | 95 | 1 g | 1,967 | |
Description: 2-CHLORO-8-FLUOROQUINAZOLINE-4-ACETIC ACID; CAS: 1784613-17-7 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire